https://scramblelifesciences.com/ Decoding Biology. Advancing Medicine. en Mon, 05 Oct 2026 22:26:48 GMT https://scramblelifesciences.com/crispr-gene-editing-safety-off-target-effects-clinical-challenges/ https://scramblelifesciences.com/crispr-gene-editing-safety-off-target-effects-clinical-challenges/ CRISPR-Cas9 rewrote the rules of molecular biology and ignited a generation of clinical ambition. But as the first wave of gene-editing therapies reaches patients, the field is confronting a harder truth: cutting the genome with precision is not the same as controlling what happens next. Off-target edits, immune reactions, and mosaic mutations remain unresolved challenges that are reshaping how scientists, clinicians, and regulators think about deploying these tools in human medicine. Scramble Life Sciences Gene Therapy & Genomic Medicine Mon, 05 Oct 2026 22:21:04 GMT https://scramblelifesciences.com/next-generation-mrna-vaccines-biotech-race-moderna-pfizer/ https://scramblelifesciences.com/next-generation-mrna-vaccines-biotech-race-moderna-pfizer/ The mRNA revolution ignited by COVID-19 vaccines is far from finished — it is, in many ways, just beginning. A new generation of biotech companies and pharmaceutical giants are engineering more stable, more versatile, and deeply personalized mRNA platforms that extend well beyond infectious disease. The stakes are enormous, the science is accelerating, and the competitive landscape has never been more consequential. Scramble Life Sciences Vaccine Science & Therapeutics Mon, 05 Oct 2026 22:21:04 GMT